A 67-year-old man with acute anterolateral myocardial infarction had recurrent ventricular fibrillation that required insertion of temporary pacemaker. When a permanent pacemaker was inserted stable ...

MENLO PARK, Calif.--(BUSINESS WIRE)--BioTrace Medical, Inc., the leader in innovative temporary cardiac pacing technology, today announced the company’s Tempo ® Temporary Pacing Lead was featured in a ...

A fully implantable, bioabsorbable pacemaker has been developed that's capable of sustaining heart rhythms in animal and human donor hearts before disappearing over 5 to 7 weeks. Temporary pacing ...

MENLO PARK, Calif.--(BUSINESS WIRE)--BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s key activities at the Annual Transcatheter Valve ...

Temporary pacing leads are getting more stage time as doctors try to head off a common heart block complication from TAVR. BioTrace Medical Inc.'s new Tempo lead aims to make temporary pacing more ...

New temporary pacing system is designed to improve patient safety, reduce costs, and enhance efficiency for transcatheter heart valve (THV) procedures. SAN FRANCISCO, March 31, 2026 /PRNewswire/ -- ...

For patients with transvenous pacemaker leads, transcatheter tricuspid valve replacement (TTVR) can be performed safely with a low risk for periprocedural complications, according to a new ...

Patients who require a new permanent pacemaker after TAVI do just as well with leadless devices out to 2 years as they do with transvenous pacemakers, according to an analysis of real-world data from ...